Hundreds of thousands of undocumented therapies occur in clinics world-wide each year under the label of ‘medical tourism’. Even if physicians in these clinics wanted to follow their patients, there has been no method of doing so. Until now. Regenetek Research recognizes that there is a high need for a method and a study design that provides proof of both safety and efficacy for new treatment interventions such as autologous stem cell therapies or unsanctioned vascular surgeries. These types of medical interventions present viable choices for patients beyond conventional drug therapies that only treat symptoms.
About: Doug Broeska
Doug Broeska is a PhD Medical Researcher and CEO of Regenetek Inc, a Canadian Biotech Research firm working with several hospitals and clinics world-wide to develop medical procedural protocols for neurodegenerative disease management.
Recent Posts by Doug Broeska
In 2009 when Paolo Zamboni came up with an original idea and clinical evidence to associate abnormal pathology in the jugular veins of MS patients to the disease process itself as a possible cause (chronic cerebrospinal venous insufficiency or CCSVI), it was a shot heard around the medical world. Could a simple two hour non-invasive medical procedure to expand neck veins really ‘cure’ a chronic, often fatal neurodegenerative disease and avoid a lifetime of misery for many MS patients? In 150 years of attempting to treat MS, could this pathophysiological abnormality and its relationship to the disease have been missed? After all, this Italian doctor Zamboni published a study that showed evidence of neurologic improvements and increased function after MS patients underwent the jugular vein-expanding procedure. And what do doctors really know about veins anyway? Not even vascular surgeons work in the veins very much. It all seemed plausible.
We honor God when we use our intelligence to create for the greater good. That honor is of the highest order when we use everything that God has given us to create something that will improve or save lives. Improving the human condition is also the ultimate act of human kindness, and I believe that all humankind is good at its core. If we accept that human beings are essentially good, it also naturally implies that we understand the difference between good and evil, or right and wrong. Interestingly, even recent psychological experiments with babies have demonstrated that they know the difference between right and wrong at a very early age, long before socialization has occurred. Knowing the difference is part of the natural instinct of man. Doing wrong comes from man being put in desperate or artificial situations.
There is no known cure for neurodegenerative diseases such as MS, ALS, Parkinson’s disease or Alzheimer’s. And there is no drug in the conventional research pipeline that would allow patients stricken with any one of these diseases to hope for a cure in their lifetime. In trial after trial, pharma-based strategies have produced nothing more than symptomatic relief; none of the chemical-based drugs targeted at brain disease have been effective, and sometimes they have been highly unsafe with serious adverse side-effects. After 50 years of attempting to find some chemical element or compound that even suggests that such an approach can direct us towards a possible cure, isn’t it just possible that pharmacological-based medicinal substances cannot be effective by themselves in this regard?
The results indicated by preliminary study data and the observation and evaluation of the subjects in the study demonstrate the reliability of improved outcomes for patients having been treated in the Regenetek study with the Combination Therapy. Because of this, there is now a further need to advance new physiotherapeutic strategies for returning patients to functional health once they have had the cellular therapy since many have been paralyzed or non-ambulatory for many years resulting in postural stress
Recent Comments by Doug Broeska
- March 9, 2014 on On Patient Advocacy, Social Media, and Final Curtains in Science: The CCSVI – MS Connection
- February 27, 2014 on On Patient Advocacy, Social Media, and Final Curtains in Science: The CCSVI – MS Connection
- February 6, 2014 on Towards a Patient Bill of Rights Part 2
- November 25, 2013 on Evidence-Based? Institutionalized Fraud in the Medical Research System
- November 22, 2013 on Evidence-Based? Institutionalized Fraud in the Medical Research System